Related Experiment Video
Updated: Aug 22, 2026
Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
Published on: December 27, 2017
[Study on bone marrow megakaryocytes in children patients with idiopathic thrombocytopenic purpura]
Tao Hu1, Xiao-Dong Shi, Yan-Ling Feng
1Department of Hematology, Capital Institute of Pediatrics, Beijing 100020, China. hutaobj@sina.com
Abstract:
To observe the morphological characteristics and hematopoietic function of bone marrow megakaryocyte (MK) in children patients with idiopathic thrombocytopenic purpura (ITP), and to preliminary analyse the cause and mechanism of thrombocytopenia. CD41 McAb immunohistochemical technique was used to detect micromegakaryocyte in bone marrow smear. Plasma clot culture and CD41 McAb immunohistochemical technique were used for the MK-colony forming assay. The results showed that there was no statistical difference of the positive rate of micromegakaryocyte between groups of ITP and control, but type I lymphocyte-like micromegakaryocyte was infrequent. The number of micromegakaryocyte and the formation rates of CFU-MK and BFU-MK in ITP group were significantly higher than those in control group. The normal MK releasing platelet could be easily found in the culture system. The MK colony formation rate was decreased in a patient with chronic ITP. In conclusion, the increment of type II, III, IV micromegakaryocytes is one of pathologic phenomenon of ITP. These small megakaryocytes can develop and mature to normal megakaryocytes in the condition of ex vivo culture. The developmental abnormity of MK is a possible reason for thrombocytopenia among partial patients with ITP, especially the chronic cases.
Insights
Idiopathic thrombocytopenic purpura (ITP) in children shows increased micromegakaryocytes, suggesting developmental abnormalities in megakaryocytes (MK) may cause low platelet counts, especially in chronic cases.
Area of Science:
- Hematology
- Immunology
- Pediatrics
Context:
- Idiopathic thrombocytopenic purpura (ITP) is an autoimmune disorder characterized by low platelet counts.
- Understanding the role of megakaryocytes (MK) in ITP pathogenesis is crucial for developing effective treatments.
Purpose:
- To investigate the morphological characteristics and hematopoietic function of bone marrow megakaryocytes (MK) in pediatric patients with ITP.
- To analyze the underlying causes and mechanisms of thrombocytopenia in ITP.
Summary:
- Immunohistochemical analysis revealed increased numbers of micromegakaryocytes (types II, III, IV) in ITP patients compared to controls.
- While micromegakaryocyte numbers were higher, their ability to form colonies (CFU-MK, BFU-MK) was also elevated, and they could mature into normal MKs in vitro.
- A decreased MK colony formation rate was observed in a chronic ITP patient, indicating potential developmental abnormalities.
Impact:
- The findings suggest that abnormal MK development is a contributing factor to thrombocytopenia in some ITP patients, particularly those with chronic disease.
- This research provides insights into the pathophysiology of ITP, potentially guiding future therapeutic strategies targeting MK development.
